§ Funding Round
Ayala Pharmaceuticals raised $30M Series B venture round, led by Novartis.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
NovartisLEAD | Organization | — |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$30M
Top Valuation
-
Ayala Pharmaceuticals raised $30M in a Series B round.
The round was announced on 05/28/19.
The round was led by Novartis.
